Noninvasive test for the diagnosis of ovarian hormone-secreting-neoplasm in postmenopausal women()

Por Cohen, Ilan, Nabriski, Dan, Fishman, Ami
Publicado no Gynecol Oncol Rep (2015)

The Mechanism of Action of the Histone Deacetylase Inhibitor Vorinostat Involves Interaction with the Insulin-Like Growth Factor Signaling Pathway

Por Sarfstein, Rive, Bruchim, Ilan, Fishman, Ami, Werner, Haim
Publicado em 2011

Metformin Downregulates the Insulin/IGF-I Signaling Pathway and Inhibits Different Uterine Serous Carcinoma (USC) Cells Proliferation and Migration in p53-Dependent or -Independent...

Por Sarfstein, Rive, Friedman, Yael, Attias-Geva, Zohar, Fishman, Ami, Bruchim, Ilan, Werner, Haim
Publicado em 2013

Novel dual-function CellDetect(® )staining technology: wedding morphology and tinctorial discrimination to detect cervical neoplasia

Por Idelevich, Pavel, Elkeles, Adi, Okon, Elimelech, Kristt, Don, Terkieltaub, Dov, Rivkin, Ilia, Bruchim, Ilan, Fishman, Ami
Publicado em 2010

Fibroblast recruitment as a tool for ovarian cancer detection and targeted therapy

Por Oren, Roni, Addadi, Yoseph, Narunsky Haziza, Lian, Dafni, Hagit, Rotkopf, Ron, Meir, Gila, Fishman, Ami, Neeman, Michal
Publicado no Int J Cancer (2016)

A phase 1/2a, dose-escalation, safety, pharmacokinetic, and preliminary efficacy study of intraperitoneal administration of BC-819 (H19-DTA) in subjects with recurrent ovarian/peri...

Por Lavie, Ofer, Edelman, David, Levy, Tally, Fishman, Ami, Hubert, Ayala, Segev, Yakir, Raveh, Eli, Gilon, Michal, Hochberg, Avraham
Publicado no Arch Gynecol Obstet (2017)